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ABSTRACT 
Comb-like amphiphilic polymers were obtained by grafting long paraffinic chains on 
microbial poly(γ,DL-glutamic acid) and poly(β,L-malic acid) through two steps, i.e. 
allylation of the carboxylic side groups followed by UV-initiated thiol-ene click reaction 
with 1-alkanethiols bearing 8, 12 and 16 carbon atoms, and their characterization was 
accomplished by 1H NMR, GPC and DSC. The grafted polymers were capable of self-
assembling in nanoparticles with diameters in the 80-240 nm range. Incubation in water 
under physiological conditions led to hydrolysis of the lateral ester bonds followed by 
scission of the polyamide or polyester main chain. The model drugs, Theophylline and 
Carbamazepine, were efficiently encapsulated in these systems with much better results 
attained for the later. Drug release from nanoparticles incubated under physiological 
conditions occurred with a burst effect and were completely discharged in 24 h. Release 
profiles recorded from drug-loaded films suggested that the drug was delivered in both 
cases through a diffusion process. 
 
Keywords: poly(γ-glutamic acid); poly(β,L-malic acid); click-reaction; drug 
encapsulation; biodegradable nanoparticles. 
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1. Introduction 
 Biodegradable polymers are currently of great interest for their use in temporal 
biomedical applications like chirurgical sutures and drug delivery systems. Among 
them, biopolymers either of natural occurrence or biotechnologically produced, stand 
out because they are bioassimilable and biocompatible [1-3]. Poly(γ-glutamic acid) 
(PGGA) and poly(β,L-malic acid) (PMLA) are microbial polymers produced by 
fermentation with bacteria and fungi respectively, that have been shown to be excellent 
candidates as biodegradable materials for medical applications. 
PGGA can be produced by several species of bacteria of the genus Bacillus, 
classified as GRAS (Generally Regarded As Safe) by the US Food and Drug 
Administration [4]. It is a water-soluble polyamide that degrades into glutamic acid 
which is an essential substance to humans [5,6]. PGGA and its derivatives are 
promising biomaterials that distinguish by being able to display functional properties 
due to the presence of the carboxylic side group attached to the polyamide main chain 
[6]. Amphiphilic PGGA derivatives can be produced by chemical modification and 
some of them have been used to prepare nanoparticles for drug and vaccine delivery 
system (DDS) [7,8]. 
PMLA is naturally produced by myxomicetes and filamentous fungi. It is a water 
soluble polyester very prone to undergo hydrolysis with formation of metabolic L-malic 
acid [9]. PMLA is also a promising building block for the design of drug delivery 
systems because its excellent biodegradability and biocompatibility and because its 
carboxylic functionality [10]. PMLA has been used as a platform in the synthesis of 
nanocarriers for drug delivery [11-15], as well as a constituent in macromolecular 
conjugates bearing several functionalities, to treat human brain and breast tumors in 
mouse models [16,17].  
 Nowadays, biodegradation and bioresorption are considered as prerequisites of any 
high molecular weight biomaterial that is to be used in human therapy [11]. This has 
stimulated the modification of naturally occurring biopolymers [18,19], as it is the case 
of PGGA and PMLA, where the  carboxylic groups make their derivatization feasible 
for the modulation of polymer hydrophobicity and properties [20,21], and for the 
introduction of bioactive ligands required for the stable association with drugs and their 
controlled release [5,22]. Graft copolymers consisting of hydrophilic and hydrophobic 
segments are capable of self-assembling in aqueous solutions to form micro or 
nanoparticles [13,23]. DDS based on polymer particles are clearly advantageous 
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because they can effectively deliver the drug to a target site and thus increase the 
therapeutic benefit, while minimizing side effects. For instance, polymer particles help 
to increase the stability of drug [3, 24-26]. 
The concept of functionalization by postpolymerization strategies makes use of 
modern techniques based on click chemistry [27]. In this context, the thiol-ene reaction 
is particularly attractive because in addition to be facile and versatile, it results in a 
stable linkage and exhibits minimal cross-reactivity with other functional groups. 
Morever, this reaction may be performed to near completion under mild conditions  
giving rise to products that are free of appreciable amounts of impurities [28]. In this 
work we will take benefit from the functionality of PGGA and PMLA for building 
amphiphilic comb-like polymers suitable for their application as DDS. PGGA and 
PMLA are functionalized through a two-step procedure based on the thiol-ene reaction. 
In the first step, the allyl group is introduced by direct esterification, which leads to a 
double-bond functionalized polymer with potential for further specific modification 
[29]. In the second step, aliphatic long chains are grafted by thiol-ene click-reaction in 
order to obtain the comb-like architecture required for nanoparticle formation and drug 
encapsulation. Drugs tested for encapsulation and drug delivery assays were 
Theophylline and Carbamazepine which are considered as hydrophilic and hydrophobic 
drug models, respectively. 
 
2. Experimental 
2.1. Materials 
Polymers used in this work were biotechnologically produced. PGGA was obtained 
by fermentation of Bacillus licheniformis, which was kindly supplied by Dr. Kubota of 
Meji Co. (Japan). It had a weight-averaged molecular weight of ~30 kDa. PMLA was 
obtained by fermentation of Physarum polycephalum, isolated and purified as described 
elsewhere [9]. It had a weight-averaged molecular weight of ~25 kDa. Purity of the both 
PGGA and PMLA samples was ascertained by 300 MHz 1H NMR. Allyl alcohol, allyl 
bromide, 1-octanethiol, 1-dodecanethiol, 1-hexadecanethiol, 2,2-dimethoxy-2-
phenylacetophenone (DMPA), dicyclohexylcarbodiimide (DCC) and Theophylline (1,3-
dimethylxanthine, THEO) were acquired from SIGMA-Aldrich, while Carbamazepine 
(5H-dibenz[b,f]azepine-5-carboxamide, CBZ) was obtained from AKSci (USA). All 
organic solvents were analytical grade and used without further purification.  
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2.2. Esterification reactions 
Esterification of PGGA with allyl bromide was carried out following the procedure 
described elsewhere for alkyl-bromides [30]. Briefly, NaHCO3 (525 mg) was added to a 
solution of 200 mg of PGGA in 20 mL of N-methylpyrrolidone (NMP) heated at 60 °C. 
Allyl bromide was slowly added in the amount required to reach the desired conversion. 
The reaction was left to proceed for 48 h and the esterified polymer was recovered by 
precipitation in diethyl ether, washed with acetone, and dried in vacuum for storage. 
Esterification of PMLA with allyl alcohol was performed through activation of the 
carboxyl side group with DCC. Briefly, a mixture of 0.5 or 0.75 mmol of DCC in 2 mL 
of allyl alcohol was added dropwise to a solution of 1 mmol of PMLA in 2 mL of allyl 
alcohol; the reaction was left to proceed for 3 h at room temperature under vigorous 
magnetic stirring. The final reaction mixture was subjected to dialysis against methanol 
for 48 h using an 8 kDa cut-off membrane. The allyl ester of PMLA was lyophilized for 
recovery and storage.  
 
2.3. Thiol-ene click reactions 
 The PGGA and PMLA 3-alkylthio-propyl esters (coPGGA-PrSRxHy and coPMLA-
PrSRxHy) were prepared as follows: To a 7.5 % (w/v) solution of the PGGA allyl ester 
in NMP at room temperature, the corresponding 1-alkanethiol (1-octanethiol, 1-
dodecanethiol, 1-hexadecanethiol) was added in a 2:1 molar ratio respect to double 
bond concentration, and then DMPA (4 %-mol respect to double bond) was added. The 
reaction mixture was placed in an UV lamp (2 x Philips PL-S 11 W/10, 360 nm) and it 
was irradiated for 24 h after which the reaction was completed according to 1H NMR. 
The grafted PGGA was recovered by pouring the reaction mixture into ethanol and the 
product was dried in vacuum for storage. The same procedure was applied for the 
preparation of the PMLA derivatives but starting from a solution of 1.5 % (w/v) of the 
PMLA allyl ester in DMSO.  
 
2.4. Particles formation and drug encapsulation 
Precipitation-dialysis was found to be a suitable procedure to produce nanoparticles 
due to the capacity of the amphiphilic copolymers, coPGGA-PrSRxHy and coPMLA-
PrSRxHy to self-assemble in layered nanostructures. Briefly, 1 mL of water was added 
dropwise to a 1 mL of 1 % solution of coPGGA-PrSRxHy in NMP or to 1 mL of 0.25 % 
solution of coPMLA-PrSRxHy in DMSO, in both cases under magnetic stirring. 
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Mixtures were dialyzed against distilled water for 24 h using a cellulose membrane of 8 
kDa Mw cut-off. Particles morphology was examined by SEM and their average 
hydrodynamic diameters and ζ potential were determined by light scattering. NPs were 
recovered by centrifugation freeze-dried. The same procedure was used for the 
preparation of the nanoparticles encapsulated with THEO or CBZ but using drug-
saturated water for the dialysis process. The drugs were added at a concentration of 20 
% (w/w) with respect to polymer in the organic solution. Samples were recovered by 
centrifugation, washed with distilled water and freeze-dried for storage. 
 
2.5. Hydrolytic degradation  
Hydrolytic degradation was studied by following the reduction in molecular weight 
as a function of incubation time. For this, fresh nanoparticles suspensions containing 2.5 
mg of nanoparticles in 1 mL of phosphate buffer pH 7.4 were prepared and incubated at 
37 °C. Samples were frozen at scheduled times and analyzed by GPC. The hydrolytic 
degradation mechanism was examined by means of 1H NMR by monitoring the changes 
taking place in the mother solution along the degradation process. For this, 10 mg of 
nanoparticles were resuspended in 1 mL of deuterated phosphate buffer pH 7.4 with 
D2O and placed in NMR tubes, and 1H NMR spectra were recorded at scheduled times.  
 
2.6. Drug-loaded films 
Drug-loaded films were prepared by casting. Briefly, 1 mL of 2 % (w/v) solution of 
either PGGA or PMLA copolymer in CHCl3 and 0.5 mL of 0.4 % (w/v) solution of 
CBZ in CHCl3 were mixed and slowly evaporated on a Teflon sheet. Films containing 
THEO were not prepared because no common solvent for polymers and drug could be 
found. DSC analysis was performed on drug-loaded films to determine the crystalline 
state of the drug in the films.  
 
2.7. In vitro drug release  
In vitro drug release of Theophylline and Carbamazepine from the loaded polymer 
was evaluated by the dialysis method. Briefly, 10 mg of drug loaded nanoparticles were 
resuspended in 1 mL of phosphate buffer pH 7.4, and transferred into a dialysis tube 
with 8 kDa molecular weight cut-off. The tube was then immersed into 20 mL of buffer 
and placed under incubation at 37 °C. 2 mL aliquots of the releasing medium were 
taken at scheduled times, and the drawn volume replaced by fresh buffer. Drug 
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concentration was determined by UV spectroscopy at 220 and 275 nm for CBZ and 
THEO, respectively. The amount of drug loaded on the particles [drug]np was 
determined by dissolving the particles in the appropriate solvent (DMSO, MeOH or 
DCM) and measuring the drug concentration by UV-vis spectrophotometry using a 
calibration curve built with the free drug. Encapsulation efficiency (EE) was calculated 
on the basis of the following formula:  
 
 % 100npi
drug
EE
drug
  
where [drug]i is the drug concentration relative to polymer (w/w) in the initial solution. 
Cumulative drug release was calculated as a function of time. The same procedure was 
employed for CBZ release from films. 
 
2.8. Measurements 
NMR spectra were recorded on a Bruker AMX-300 instrument from samples 
dissolved either in DMSO-d6 or CDCl3 containing minor amounts of trifluoroacetic 
acid. Degradation products were analyzed in the same aqueous buffer used for 
incubation using D2O instead of H2O. 1H NMR spectra where recorded at 25 °C 
operating at 300.1 MHz; 128 scans were acquired with 32K data points and relaxation 
delays of 2 seconds. UV spectrophotometry was performed in a UV-visible 
spectrophotometer CECIL CE 2021. Gel permeation chromatography (GPC) was done 
using a Waters 515 HPLC pump provided with a Waters 410 differential refractometer 
detector and a Waters Styragel HR 5E column (7.8 x 300 mm) (Waters, Massachusetts, 
USA). Samples were chromatographed using 0.05 M sodium trifluoroacetate in 
hexafluoroisopropanol at 0.5 mL·min-1 flow rate. Chromatograms were calibrated 
against poly(methyl methacrylate) standards (Varian, USA). DSC analysis was made 
using a Perkin-Elmer Pyris 1 apparatus. Thermograms were obtained from 2-4 mg 
samples at heating and cooling rates of 10 °C·min-1, under nitrogen flow. Indium and 
zinc were used as standards for temperature and enthalpy calibrations.  
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3. Results and discussion 
3.1. Comb-like polymers synthesis 
Comb-like copolymers from PGGA and PMLA were obtained by a two-step 
process (Scheme 1). First, polymers were allylated at various degrees using specific 
procedures for PGGA and PMLA according to the different susceptibility towards 
hydrolysis displayed by their main chains. PGGA was esterified with allyl bromide 
under middle-basic conditions whereas allyl alcohol was used for esterifying PMLA 
with the concourse of DCC as carboxylic activator. Results for the allylation reaction 
are collected in Table 1. The degree of esterification (%-mol) was determined by 
integration and relative quantification of the 1H NMR signals arising from the main 
polymer chain (CH signal appearing in the 4.2-4.3 or 5.2-5.4 ppm range for PGGA or 
PMLA derivatives, respectively) and the allyl side group OCH2 signal appearing at 4.7 
ppm. Reaction yields were between 88 and 96% for PGGA and between 75 and 80% for 
PMLA.  
<Insert Scheme 1> 
<Insert Table 1> 
The resulting allylated copolymers were spectroscopycally pure as it was proved by 
1H NMR. In fact, the occurrence of allylation of polyacids was clearly evidenced by 
following the changes taking place in the 1H NMR spectra (Figures 1 and 2). For PGGA 
the signal of the allylic CH2 appearing at 4.1 ppm in allyl bromide (spectrum 1b, signal 
e) shifted 0.5 ppm downfield in coPGGA-Al50H50 (spectrum 1c, signal e'). In the case of 
PMLA, a similar displacement was observed for the allylic CH2 signal which moved 0.7 
ppm downfield when the allyl alcohol entered in the PMLA as alcohyl group (signal c 
in spectrum b compared to signal c’ in spectrum 2c). Molecular weights were found to 
increase proportionally to the esterification degree, while copolymers polydispersities 
displayed similar values for the two copolymer series. 
<Insert Figure 1 and 2> 
Grafting of the three linear 1-alkanethiols containing 8 (Oc), 12 (dD) and 16 (hD) 
carbon atoms on allyl functionalized polymers was successfully achieved taking 
advantage of the high reactivity and specificity of the thiol-ene click reaction. DMPA 
was chosen as photoiniciator and UV radiation as activator. The reaction is known to 
take place as a free radical reaction initiated by decomposition of DMPA and to proceed 
with propagation to terminate by radical chain transfer [31]. Conversion degree for all 
copolymers was practically 100% as it could be assessed by 1H NMR. In fact proton 
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signals arising from the double bound (5-6 ppm) fully disappeared after reaction 
(spectra 1d and 2d in Figure 1 and 2, respectively), indicating that the totality of allyl 
groups had been converted. Nevertheless, reactions yields were relatively lower than for 
the first step, i.e. between 60 and 80% for PGGA and around 45% for PMLA 
derivatives (Table 2). Losses could be due in part to photodegradation taking place by 
the prolonged exposition of the polymer to UV radiation. Shorter exposition times were 
assayed but then reaction did not reach completeness. Such degradation was reflected in 
the molecular weights of the grafted copolymers which were found to be slightly lower 
than those of their respective allylated precursors. Nevertheless, Mw values for the three 
alkylated derivatives coming from each copolymer composition were consistent with 
the length of the alkylthiol used for grafting at each case (Table 2). 
<Insert Table 2> 
 
3.2. Thermal characterization 
A DSC calorimetric study was carried out in order to appraise the crystalline 
character of the grafted copolymers since previous works on similar comb-like systems 
had shown that long linear alkyl side chains are able to crystallize in a phase separated 
from that containing the main chains [21]. As it is observed in Figure 3, only 
copolymers bearing the hexadecyl group displayed endothermal peaks characteristic of 
melting, and this happens for both PGGA and PMLA and for whichever composition. In 
all cases, the melting temperature was in the 40-60 ºC range, which is a value fully 
consistent with what should be expected for the melting of a paraffinic crystal made of 
alkyl chains of sixteen carbon atoms. Note that multiple melting peaks are observed in 
some of these DSC traces which could be attributed to the occurrence of multiple 
crystallite populations differing in size. This is a phenomenon commonly taking place 
upon polymer crystallization. It is interestingly noticed that peak multiplicity becomes 
more evident for 50% copolymer compositions suggesting that it is influenced by the 
density of alkyl side chains. These results are in agreement with what has been reported 
for poly(α-alkyl-γ-glutamate)s which were found to be able to crystallize only for alkyl 
chains containing at least 14 carbon atoms [21]. It can be concluded therefore that the 
sulphur atom is unable to enter in the paraffinic crystal lattice and consequently the 
thiotrimethylene group must remain in a disordered interphase connecting the alkyl side 
chains to the backbone of the polypeptide or polyester chains through the carboxylate 
group.  
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<Insert Figure 3 > 
 
3.3. Nanoparticles formation and characterization 
The amphiphilic polymers created by esterification were capable to spontaneously 
form self-assembled nanostructures when the precipitation dialysis method was applied. 
More or less spherical nanoparticles were obtained for coPGGA-PrSR50H50, coPGGA-
PrSR75H25, coPMLA-PrSR50H50 and coPMLA-PrSR75H25 (Figure 4 and 5), whereas 
coPGGA-PrSR25H75 failed to form particles under the applied conditions. Average 
hydrodynamical diameters of these particles oscillated from 80 to 240 nm (Table 3), 
with smaller sizes corresponding to PGGA derivatives. Although there is not apparent 
correlation between composition and size, a general observation is that polymers 
containing hexadecyl chains produced the smallest particles, which is probably due to 
the contraction implied in the crystallization that takes place in these systems.  
<Insert Figure 4 and 5> 
Particle surface charge was estimated by measuring the ζ-potential in distilled water 
and results are included in Table 3. Nanoparticles displayed negative charge values 
according to the presence of free carboxylic groups present in the copolymers derived 
from both PGGA and PMLA. On the basis of well-settled amphiphilic self-assembled 
particle structure concept it can be reasonably assumed that the carboxylic grafted 
chains are hidden in the inner part to form a core-shell structure. The negative charge 
decreases with increasing conversion degree, which is in accordance with what should 
be expected for the variation in the negative hydrophilic/neutral hydrophobic ratio. It is 
noteworthy that the observed differences are higher for PMLA derivatives, which is 
probably due to the greater ability of the flexible polymalate chain to be sterically 
accommodated in the particle. 
<Insert Table 3> 
 
3.4. Hydrolytic degradation 
The hydrolytic degradation of the nanoparticles was examined upon incubation in 
water under physiological conditions, i.e. pH 7.4 and 37 °C (Figure 6). Degradation rate 
was determined by following the molecular weight reduction as a function of incubation 
time. As it was expected the susceptibility of nanoparticles to hydrolysis decreased for 
higher conversion degrees and longer alkyl side chain lengths. Both factors, 
esterififcation degree and lateral chain length, are directly related to the material 
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hydrophobicity, and therefore to the sensitiveness to hydrolysis of the copolymers. 
PMLA copolymer derivatives displayed a much higher rate of hydrolysis than those of 
PGGA because the greater lability of the main chain ester bond compared to the amide 
bond. The degradation profiles depicted in Figure 6 show that after 12 weeks of 
incubation, coPGGA-PrSOc50H50 retained about 60 % of its original molecular weight, 
while for coPGGA-PrShD50H50 the value was above 80 %. Conversely, in PMLA 
derivatives, the coPMLA-PrSOc50H50 molecular weight fell down to 35 % of its original 
value while for coPMLA-PrShD50H50 it remained around 70 %. The hydrolysis rate of 
polymers with 75% of modified  units was significantly slower so that  only those 
containing the octyl group showed a considerable molecular weight reduction upon 
incubation whereas those bearing longer side chains retained more than 90% of their 
original molecular weight. 
<Insert Figure 6> 
The hydrolysis mechanism was studied with the support of 1H NMR analysis of the 
soluble products that are released to the aqueous medium upon incubation. According to 
the results found in the degradation rate assays, copolymers modified at lower 
conversion degrees with shorter alkyl side chains degraded considerably faster and 
PGGA series were more resistant than the PMLA ones. Nevertheless the degradation 
mechanism seems to be common to all of them. Since coPGGA-PrSOc50H50 and 
coPMLA-PrSOc50H50 were the most degraded samples in the PGGA and PMLA 
copolyesters series respectively, and their degradation products are water-soluble, they 
were chosen to study the degradation mechanism operating in each series. First 
detectable 1H NMR signals in the degradation of coPGGA-PrSOc50H50 appeared after 
one month of incubation (Figure 7). They were assigned to protons attached to the main 
chain carbons of glutamyl residues and to the protons of the alkylthioalkanol revealing 
the hydrolysis of the ester side group with subsequent solubilization of PGGA 
fragments enriched in free carboxylic groups. After two months of degradation, end 
group signals indicative of hydrolysis of the amide bonds from the main chain started to 
be observable. From the third month ahead, these signals increased in intensity and 
those arising from the main chain displayed much better resolution. Although formation 
of free glutamic acid as final degradation product is expected, the presence of this 
compound in the aqueous medium could not be ascertained because overlapping of its 
signals with those arising from both polymer and oligomer species. 
<Insert Figure 7> 
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For PMLA derivatives the mechanism was found to be similar although 
degradation happened faster (Figure 8). In this case, first signals appeared just after one 
week of incubation and they corresponded to the protons of free malic acid and the 
hydrolyzed side chain, indicating that hydrolysis of ester groups, in both main chain and 
side chain, took place at the same time. Upon longer times of incubation no signals 
arising from terminal groups or main chain malate units were observed in the aqueous 
solution which is taken as indicative of the non-solubility of the copolymer fragments. 
After several weeks, spectra became simplified and signals appeared intensified so that 
at the end of the incubation period, the only visible signals were those arising from free 
malic acid and the released alkylthioalkanol.  
<Insert Figure 8> 
 
3.5. Drug encapsulation and in vitro release 
Carbamazepine (CBZ) and Theophylline (THEO) were used as model compounds 
for hydrophobic and hydrophilic drugs, respectively, for both encapsulation and 
releasing studies. The encapsulation method applied in this work was the same 
precipitation dialysis method used for nanoparticle formation but adding the drug to the 
polymer solution prior to nanoparticle formation. Results obtained for the two drugs in 
the two series of copolymers are summarized in Table 3. It is apparent that CBZ is able 
to accommodate much better in the nanoparticles than THEO showing considerable 
higher encapsulation efficiency (EE) in all cases. The lower encapsulation efficiency 
found for THEO compared to CBZ may be merely a consequence of greater drug losses 
occurring at the dialysis stage caused by its higher water affinity.  
 In vitro drug release assays were carried out under physiological conditions, i.e. pH 
7.4 and 37 °C and results are depicted in Figure 9. Both drugs displayed a burst release 
within the first hours of incubation, a fact that was more pronounced for encapsulated 
THEO nanoparticles, which discharged about 60-80 % of the loaded drug in the first 
two hours of incubation. CBZ loaded nanoparticles showed a more sustained release 
needing about six hours to liberate 50% of the encapsulated drug. From these results it 
can be inferred that differences in releasing rates must be mainly determined by the 
hydrophobicity of the encapsulated compound. Given both the higher encapsulation 
efficiency attained for CBZ and the more sustained release displayed by this drug, it can 
be concluded that the derivatives examined in this work are more suitable for the design 
of DDS systems loaded with hydrophobic drugs.  
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<Insert Figure 9> 
To understand the process governing drug release in the nanoparticles, CBZ loaded-
films of both PGGA and PMLA copolymers were prepared and subjected to release 
assays. To get insight of the state of CBZ in the films, they were analyzed by DSC and 
compared to both those made of pure polymer and the blends prepared by physical 
mixing of the polymer and the drug. As it is seen in Figure 10, the DSC trace of CBZ 
showed a characteristic melting peak at 180-190 °C, which was also present in traces 
recorded from the physical blends but not from drug-loaded films, suggesting that the 
drug became well dispersed in the polymeric matrix. Incubation of the drug-loaded 
films showed that, although releasing happened at slower rates than for nanoparticles, 
the drug became almost completely liberated in the first two days (Figure 11). 
Furthermore, release rates were faster for films made of copolymers with lower 
modification degrees and bearing shorter aliphatic chains. Again drug release has to be 
related to the hydrophobicity of the material and water penetration capability. Given the 
similitude of behavior observed for films and nanoparticles, it can be reasonably 
assumed that the same diffusion process must govern drug release in both systems. The 
conclusion is therefore that drug release of CBZ from these materials must be governed 
by a diffusion process since degradation of the copolymers requires much longer 
periods of time.  
<Insert Figure 10 and 11> 
 
4. Conclusions 
Microbial polymalic and polyglutamic acids were modified by grafting long alkyl 
chains through a two-step process that makes use of thiol-ene click reactions. The 
prepared amphiphilic copolymers were able to self-assemble in aqueous media into 
nanostructurated particles with diameters within the 80- 240 nm range, the smaller ones 
being those prepared from PGGA derivatives. These nanoparticles were degraded by 
hydrolysis under physiological conditions at a rate faster for PMLA than for PGGA 
derivatives as correspond to differences expected between polyesters and polyamides. 
Degradation happened by releasing the corresponding thioether alcohol and either malic 
or glutamic acid to the medium. THEO and CBZ were encapsulated in the polymer 
nanoparticles with better efficiency for the hydrophobic drug CBZ than for the 
hydrophilic THEO. Both drugs were released upon incubation of the nanoparticles in 
water at pH 7.4 and 37 °C displaying a burst release in the first few hours to reach 
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almost completion after 24 h of incubation. The CBZ release profile obtained from 
drug-loaded films suggested that the drug was liberated through a mediated-diffusion 
process. 
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Captions to figures 
 
Scheme 1. Two-step grafting of aliphatic long chains into: a) PGGA and b) PMLA. 
 
Figure 1. 1H NMR spectra of: a) PGGA, b) allyl bromide, c) coPGGA-Al50H50 and d) coPGGA-
PrSOc50H50. *DMSO-d5H/H2O. 
 
Figure 2. 1H NMR spectra: a) PMLA, b) allyl alcohol, c) coPMLA-Al50H50 and d) coPMLA-
PrSOc50H50. *DMSO-d5H/H2O. 
 
Figure 3. DSC traces (first heating) of coPGGA-PrSRxHy a) and coPMLA-PrSRxHy b) with 
alkyl groups containing 8 (Oc), 12 (doD) and 16 (hD) carbon atoms, as indicated. 
 
Figure 4. SEM micrographs of modified PGGA nanoparticles: a) coPGGA-PrSOc50H50, b) 
coPGGA-PrSdD50H50, c) coPGGA-PrShD50H50, d) coPGGA-PrSOc75H25, e) coPGGA-
PrSdD75H25 and f) coPGGA-PrShD75H25.  
 
Figure 5. SEM micrographs of modified PMLA nanoparticles: a) coPMLA-PrSOc50H50, b) 
coPMLA-PrSdD50H50, c) coPMLA-PrShD50H50, d) coPMLA-PrSOc75H25, e) coPMLA-
PrSdD75H25 and f) coPMLA-PrShD75H25.  
 
Figure 6. Evolution of the molecular weight of copolymers incubated under physiological 
conditions a) coPGGA-PrSRxHy and b) coPMLA-PrSRxHy. 
 
Figure 7. Evolution of the 1H NMR spectrum recorded from coPGGA-PrSOc50H50 nanoparticles 
incubated in aqueous medium at pH 7.4 and 37 ºC.  
 
Figure 8. Evolution of the 1H NMR spectrum recorded from coPMLA-PrSOc50H50 
nanoparticles incubated in aqueous medium at pH 7.4 and 37 ºC.  
 
Figure 9. Drug release profiles for coPGGA-PrSRxHy (top) and coPMLA-PrSRxHy (bottom) 
nanoparticles incubated under physiological conditions and loaded with Carbamazepine (a, a’) 
and Theophylline (b, b’). 
 
Figure 10. DSC heating traces of a) pristine polymer, b) physical blend (polymer + CBZ), and 
c) CBZ loaded film. Left: coPGGA-PrSRxHy;; Right: coPMLA-PrSRxHy. For comparison, the 
trace of CBZ is included in the bottom of each set.  
 
Figure 11. Carbamazepine release from drug-loaded films. a) coPGGA-PrSRxHy and b) 
coPMLA-PrSRxHy. 
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Table 1. Step 1: Reaction conditions, conversion degrees, yields and molecular weights obtained 
for the different polymers. 
 Feeda(mol:mol) 
 
Esterification 
(%-mol) 
Yield 
(%) 
 Mwb Ðb 
PGGA - - -  30,000 - 
coPGGA-Al25H75 1 : 0.25 26 88  30,600 2.9 
coPGGA-Al50H50 1 : 0.50 55 96  37,900 2.3 
coPGGA-Al75H25 1 : 0.75 73 92  44,200 2.6 
       
PMLA - - -  25,000 - 
coPMLA-Al50H50 1 : 0.50 48 79  27,300 2.8 
coPMLA-Al75H25 1 : 0.75 73 75  33,500 3.0 
a Molar ratio of PGGA to allyl bromide  or PMLA to DCC. 
b Weight-average molecular weight and dispersity estimated by GPC. 
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Table 2. Step 2: Results of the thiol-ene click reaction on allylated PGGA and PMLA.  
Polymer Conversion 
% 
Yield 
% 
 Mwa Ða  
coPGGA-PrSOc25H75 100 61  25,200 2.5 
coPGGA-PrSdD25H75 100 62  27,800 2.6 
coPGGA-PrShD25H75 100 78  30,600 2.8 
      
coPGGA-PrSOc50H50 100 67  29,000 2.9 
coPGGA-PrSdD50H50 100 74  31,800 2.3 
coPGGA-PrShD50H50 100 64  33,200 2.3 
      
coPGGA-PrSOc75H25 100 60  30,300 2.6 
coPGGA-PrSdoD75H25 100 79  33,700 2.8 
coPGGA-PrShxD75H25 100 76  35,300 3.0 
 
 
     
coPMLA-PrSOc50H50 100 49  31,000 2.1 
coPMLA-PrSdoD50H50 100 49  32,100 2.2 
coPMLA-PrShxD50H50 100 50  33,400 2.4 
      
coPMLA-PrSOc75H25 100 51  33,100 2.0 
coPMLA-PrSdoD75H25 100 47  36,300 2.4 
coPMLA-PrShxD75H25 100 56  38,700 2.8 
a Weight-average molecular weight and dispersity estimated by GPC.  
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Table 3. Nanoparticle characterization and drug content and encapsulation efficiency for 
Carbamazepine and Theophylline. 
     CBZ THEO 
 Size 
(nm) 
I.D.a ζ-pot 
(mV) 
 Cont. 
(%) 
E.E. 
(%) 
Cont. 
(%) 
E.E. 
(%) 
coPGGA-PrSOc50H50 194 0.408 -30.2  3.18 15.9 0.54 2.7 
coPGGA-PrSdD50H50 157 0.294 -33.5  4.15 20.7 0.65 3.2 
coPGGA-PrShD50H50 76 0.155 -32.1  7.68 38.4 1.74 8.7 
         
coPGGA-PrSOc75H25 138 0.157 -29.9  5.36 26.8 2.70 13.5 
coPGGA-PrSdD75H25 135 0.160 -28.4  3.38 16.9 1.99 9.9 
coPGGA-PrShD75H25 144 0.203 -28.5  1.85 9.2 1.61 8.0 
         
coPMLA-PrSOc50H50 197 0.383 -40.6  5.8 29.0 4.1 20.5 
coPMLA-PrSdD50H50 236 0.544 -32.3  6.4 32.0 3.8 19.0 
coPMLA-PrShD50H50 170 0.335 -29.0  6.9 34.5 2.8 13.9 
         
coPMLA-PrSOc75H25 206 0.343 -35.3  5.9 29.5 1.7 8.5 
coPMLA-PrSdD75H25 239 0.486 -24.8  5.7 28.5 1.1 5.5 
coPMLA-PrShD75H25 151 0.348 -12.7  4.9 24.5 1.4 7.0 
a Dispersity index of particle sizes. 
 
 
 
